Immune-metabolic PET/MRI uncovers microenvironmental reprogramming under combined immunotherapy and anti-angiogenic therapy
Sixing Li, Marie-Aline C. Neveu, Laura Kuebler, Stefania Pezzana, Ainara Barco-Tejada, Ian WILSON, Irene González-Menéndez, Leticia Quintanilla‐Martínez, Dominik Sonanini, Andreas M. Schmid, Manfred Kneilling, André F. Martins
The paper evaluates ICI-sorafenib combination therapy in TNBC using multimodal imaging and ex vivo analyses, showing tumor growth suppression and TME remodeling.
bioRxiv · Aug 7, 2026 · PreprintCancer Biology